Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|delisted at the request of the Company under listing rule 17.11, following confirmation of the implementation of the scheme of arrangement by which QIAGEN Australia Holding Pty Ltd is now the sole shareholder in the Company||30/08/2011|
|we understand Cellestis shareholders received Scheme Consideration of $3.74 per Cellestis share from QIAGEN Australia Holding Pty Ltd and a Special Dividend of $0.06 per Cellestis Share, together representing Total Cash Payments of $3.80 per Cellestis share||30/08/2011|
|the securities of Cellestis Limited (the "Company") will be suspended from quotation at the close of trading today, 10 August 2011, at the request of the Company, following lodgement with ASIC of the court order approving the scheme of arrangement between the Company and its shareholders to effect the acquisition of the Company by QIAGEN Australia Holding Pty Limited||10/08/2011|
|we understand that on or about this date the company undertook, proposed to undertake or was the subject of the following corporate action: - Qiagen Australia Holdings Pty Limited to acquire shares - this corporate event may appear elsewhere in this company record||28/07/2011|
|NAME||TITLE||DATE OF APPOINTMENT||DATE OF RESIGNATION|
Date of first appointment, title may have changed.